search
Back to results

vNOTES Transvaginal Endoscopic Surgery Versus Laparoscopy (NOTRANDO)

Primary Purpose

Salpingectomy

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
vNOTES
laparoscopy
Sponsored by
Hospices Civils de Lyon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Salpingectomy focused on measuring vNOTES, laparoscopy, salpingectomy, pain

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • planned surgery procedure : bilateral salpingectomy for outpatient benign indication
  • patients with free, informed and signed consent

Exclusion Criteria:

  • disorders leading to an unacceptable risk of postoperative complications sought during the interrogation of the patient (disorders of blood coagulation, disorders of the immune system, progressive diseases ....)
  • pregnancy or wish for subsequent pregnancy
  • lactating women
  • intervention in the context of pelvic cancer
  • history of uni- or bilateral salpingectomy
  • contraindication to laparoscopy
  • history of rectal surgery
  • endometriosis
  • pelvic inflammatory disease
  • genital infection
  • not eligible for outpatient care
  • associated surgical procedure planned during the intervention (hysterectomy, sub-urethral strip, prolapse cure ...)
  • participation in another interventional research related to the gynecological sphere
  • inability to understand the information given
  • a person not affiliated to a social security scheme, or deprived of liberty, or under guardianship.

Sites / Locations

  • Hospices Civils de LyonRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

vNOTES

laparoscopy

Arm Description

vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) is vaginal surgery with a natural approach. The GelPOINT V-path transvaginal access platform is used. It is a device designed to be placed transvaginally to establish a pathway for the insertion of minimally invasive instruments while maintaining insufflation to perform diagnostic or operative procedures. This device also allows a passage for the extraction of operating parts.

conventional laparoscopy

Outcomes

Primary Outcome Measures

Pain score (VAS)
Visual analogic scale (VAS) is used to evaluate from 0 (no pain) to 10 (unbearable pain)

Secondary Outcome Measures

Pain score (VAS)
Visual analogic scale (VAS) is used to evaluate from 0 (no pain) to 100 mm (unbearable pain)
Pain score (VAS)
Visual analogic scale (VAS) is used to evaluate from 0 (no pain) to 100 mm (unbearable pain)
pain score (VAS)
Visual analogic scale (VAS) is used to evaluate from 0 (no pain) to 100 mm (unbearable pain)
pain score (QDSA)
Pain score assessed by QDSA short questionnaire (Saint-Antoine Pain Questionnaire) : list of 16 qualifiers to describe pain, score ranging from 0 to 64
pain score (QDSA)
Pain score assessed by QDSA short questionnaire (Saint-Antoine Pain Questionnaire) : list of 16 qualifiers to describe pain, score ranging from 0 to 64
pain score (QDSA)
Pain score assessed by QDSA short questionnaire (Saint-Antoine Pain Questionnaire) : list of 16 qualifiers to describe pain, score ranging from 0 to 64
ease of performing the technique score (VAS)
Visual analogic scale (VAS) is used to evaluate from 0 (very easy) to 100 mm (very difficult).
duration of surgery
duration of surgery (between incision and closure) in minutes
Surgery complications
Description of all per and postoperative complications
outpatient care
number of patients discharged from hospital on the same day of the intervention
dose of morphine
total dose of morphine (mg) administered in the post-interventional surveillance room
dose of analgesic
total administered dose of analgesic supplement (mg) in post-interventional monitoring room
duration of analgesic
duration of analgesic treatment (min) in post-interventional monitoring room
dose of analgesic
total administered dose of analgesics (mg) during the hospital stay
duration of analgesic
duration of analgesic treatment (hours) during the hospital stay
dose of analgesic
total administered dose of analgesics (mg) during the month following the surgery
duration of analgesic
duration of analgesic treatment (days) during the month following the surgery
quality of life score
assessed by the questionnaire SF-12 (abridged version of the Medical Outcomes Study Short-Form General Health Survey SF-36). It allows to obtain 2 scores: mental and social score (from 5.89058 to 71.966825) and physical score (from 9.94738 to 70.02246). The average of this scores in the general population is 50.
symptom improvement score
assessed by the questionnaire PGI-I (Patient Global Impression of Improvement ) (from 1 "much better" to 7 "much worse")
patient satisfaction score
Visual analogic scale (VAS) is used to evaluate from 0 (not at all satisfied) to 100 mm (very satisfied).
patient management costs
Patient management costs according to the two surgical strategies

Full Information

First Posted
March 25, 2020
Last Updated
February 6, 2023
Sponsor
Hospices Civils de Lyon
search

1. Study Identification

Unique Protocol Identification Number
NCT04324034
Brief Title
vNOTES Transvaginal Endoscopic Surgery Versus Laparoscopy
Acronym
NOTRANDO
Official Title
Randomized Study Comparing Endoscopic Transvaginal vNOTES Surgery to Laparoscopy in Terms of Postoperative Pain
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 3, 2021 (Actual)
Primary Completion Date
January 2, 2026 (Anticipated)
Study Completion Date
January 2, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospices Civils de Lyon

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The feasibility and safety of laparoscopy are no longer to be demonstrated, especially in the field of gynecology, but this technique often causes post-operative pain. New techniques are being developed to overcome the inconvenience of laparoscopy, notably endoscopic transluminal surgery using a natural orifice (NOTES). It avoids incisions and therefore scarring, and could reduce post-operative pain. It is now developing in the field of transvaginal gynecology (vNOTES). This study is the first prospective randomized study comparing the vNOTES technique to laparoscopy with postoperative pain assessment for performing a salpingectomy. The hypothesis is that the use of vNOTES transvaginal endoscopic surgery would reduce the post-operative pain of patients compared to laparoscopy in the context of a salpingectomy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Salpingectomy
Keywords
vNOTES, laparoscopy, salpingectomy, pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
vNOTES
Arm Type
Experimental
Arm Description
vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) is vaginal surgery with a natural approach. The GelPOINT V-path transvaginal access platform is used. It is a device designed to be placed transvaginally to establish a pathway for the insertion of minimally invasive instruments while maintaining insufflation to perform diagnostic or operative procedures. This device also allows a passage for the extraction of operating parts.
Arm Title
laparoscopy
Arm Type
Active Comparator
Arm Description
conventional laparoscopy
Intervention Type
Device
Intervention Name(s)
vNOTES
Intervention Description
vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) is vaginal surgery with a natural approach. The GelPOINT V-path transvaginal access platform is used. It is a device designed to be placed transvaginally to establish a pathway for the insertion of minimally invasive instruments while maintaining insufflation to perform diagnostic or operative procedures. This device also allows a passage for the extraction of operating parts.
Intervention Type
Procedure
Intervention Name(s)
laparoscopy
Intervention Description
The surgery by conventional laparoscopy is used
Primary Outcome Measure Information:
Title
Pain score (VAS)
Description
Visual analogic scale (VAS) is used to evaluate from 0 (no pain) to 10 (unbearable pain)
Time Frame
Day 1 (the day after surgery)
Secondary Outcome Measure Information:
Title
Pain score (VAS)
Description
Visual analogic scale (VAS) is used to evaluate from 0 (no pain) to 100 mm (unbearable pain)
Time Frame
Day 0 (Hour 2 post surgery)
Title
Pain score (VAS)
Description
Visual analogic scale (VAS) is used to evaluate from 0 (no pain) to 100 mm (unbearable pain)
Time Frame
Day 0 (Hour 6 post surgery)
Title
pain score (VAS)
Description
Visual analogic scale (VAS) is used to evaluate from 0 (no pain) to 100 mm (unbearable pain)
Time Frame
Day 7
Title
pain score (QDSA)
Description
Pain score assessed by QDSA short questionnaire (Saint-Antoine Pain Questionnaire) : list of 16 qualifiers to describe pain, score ranging from 0 to 64
Time Frame
Day 0 (Hour 6 post surgery)
Title
pain score (QDSA)
Description
Pain score assessed by QDSA short questionnaire (Saint-Antoine Pain Questionnaire) : list of 16 qualifiers to describe pain, score ranging from 0 to 64
Time Frame
Day 1 (the day after surgery)
Title
pain score (QDSA)
Description
Pain score assessed by QDSA short questionnaire (Saint-Antoine Pain Questionnaire) : list of 16 qualifiers to describe pain, score ranging from 0 to 64
Time Frame
Day 7
Title
ease of performing the technique score (VAS)
Description
Visual analogic scale (VAS) is used to evaluate from 0 (very easy) to 100 mm (very difficult).
Time Frame
Day 0 (30 minutes after surgery)
Title
duration of surgery
Description
duration of surgery (between incision and closure) in minutes
Time Frame
Day 0 (30 minutes after surgery)
Title
Surgery complications
Description
Description of all per and postoperative complications
Time Frame
Month 1
Title
outpatient care
Description
number of patients discharged from hospital on the same day of the intervention
Time Frame
Day 1
Title
dose of morphine
Description
total dose of morphine (mg) administered in the post-interventional surveillance room
Time Frame
Day 0 (2 hours post surgery)
Title
dose of analgesic
Description
total administered dose of analgesic supplement (mg) in post-interventional monitoring room
Time Frame
Day 0 (2 hours post surgery)
Title
duration of analgesic
Description
duration of analgesic treatment (min) in post-interventional monitoring room
Time Frame
Day 0 (2 hours post surgery)
Title
dose of analgesic
Description
total administered dose of analgesics (mg) during the hospital stay
Time Frame
Day 0 (8 hours post surgery)
Title
duration of analgesic
Description
duration of analgesic treatment (hours) during the hospital stay
Time Frame
Day 0 (8 hours post surgery)
Title
dose of analgesic
Description
total administered dose of analgesics (mg) during the month following the surgery
Time Frame
month 1
Title
duration of analgesic
Description
duration of analgesic treatment (days) during the month following the surgery
Time Frame
month 1
Title
quality of life score
Description
assessed by the questionnaire SF-12 (abridged version of the Medical Outcomes Study Short-Form General Health Survey SF-36). It allows to obtain 2 scores: mental and social score (from 5.89058 to 71.966825) and physical score (from 9.94738 to 70.02246). The average of this scores in the general population is 50.
Time Frame
month 1
Title
symptom improvement score
Description
assessed by the questionnaire PGI-I (Patient Global Impression of Improvement ) (from 1 "much better" to 7 "much worse")
Time Frame
month 1
Title
patient satisfaction score
Description
Visual analogic scale (VAS) is used to evaluate from 0 (not at all satisfied) to 100 mm (very satisfied).
Time Frame
month 1
Title
patient management costs
Description
Patient management costs according to the two surgical strategies
Time Frame
month 1

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: planned surgery procedure : bilateral salpingectomy for outpatient benign indication patients with free, informed and signed consent Exclusion Criteria: disorders leading to an unacceptable risk of postoperative complications sought during the interrogation of the patient (disorders of blood coagulation, disorders of the immune system, progressive diseases ....) pregnancy or wish for subsequent pregnancy lactating women intervention in the context of pelvic cancer history of uni- or bilateral salpingectomy contraindication to laparoscopy history of rectal surgery endometriosis pelvic inflammatory disease genital infection not eligible for outpatient care associated surgical procedure planned during the intervention (hysterectomy, sub-urethral strip, prolapse cure ...) participation in another interventional research related to the gynecological sphere inability to understand the information given a person not affiliated to a social security scheme, or deprived of liberty, or under guardianship.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Gery LAMBLIN, Pr
Phone
(0)4 72 35 58 71
Ext
+33
Email
gery.lamblin@chu-lyon.fr
Facility Information:
Facility Name
Hospices Civils de Lyon
City
Bron
ZIP/Postal Code
69677
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
LAMBLIN Géry

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

vNOTES Transvaginal Endoscopic Surgery Versus Laparoscopy

We'll reach out to this number within 24 hrs